Demonstrates enhanced detection of synthetic breath biomarkers in a novel SERS platform, suggesting practical diagnostic applications.
Volatile organic compounds (VOCs) are valuable health indicators, with synthetic breath biomarkers offering rapid and disease-specific diagnostics. However, their <100 ppb level exhalation requires mass spectrometry, limiting clinical integration. Surface-enhanced Raman spectroscopy (SERS) offers a portable, cost-effective alternative. Yet, detecting synthetic breath biomarkers, with inherently low Raman cross-sections, at <100 ppb remains challenging. We demonstrate SERS detection down to clinically relevant 10 ppb via water-mediated trapping in hydroxylated nanoporous silica-coated plasmonic nanogaps, using pentafluoropropylamine (PFP) as a representative synthetic breath biomarker. Uniform nanogaps, with >10³ electric field enhancement, were generated between a gold film and gold-silica core-shell nanoparticle assemblies using electric field-driven evaporation. Oxygen plasma treatment hydroxylated the silica, enabling water-mediated hydrogen bonding that strengthened PFP adsorption, confirmed by density functional theory. This mechanism improved SERS sensitivity by 10⁴-fold, enabling ppb level PFP detection in mouse bronchial fluid and establishing a VOC capturing SERS platform for breath-based diagnostics.
No takes yet. Share an insight, caveat, or question.
Garg et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: